Clinical Oncology
- Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study (2021)
- Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain? (2012)
- Reply to the Comments on Comparative Study with New Accuracy Metrics for Target Volume Contouring in PET Image Guided Radiation Therapy (2013)
- Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Utility of Trial-estimated Prognostic Models. (2017)
- Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study (2022)
- Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study (2022)
- Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study) (2023)
- Resistance, not tachyphylaxis or tolerance (2012)
- Retrospective, Registry-based, Cohort Investigation of Clinical Outcomes in Patients with Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in Finland (2022)
- Rintasyöpä (2018)





